Maternal, Renal, and Musculoskeletal Adaptations to Pregnancy

Anatomy and renal changes during pregnancy

During pregnancy, several anatomical adaptations occur in the kidneys that can lead to hydronephrosis. Hydronephrosis is the distension of the renal pelvis and calyces, allowing the kidneys to hold an increased volume of urine. The mechanism is driven by hormones, particularly progesterone and relaxin, which cause relaxation of smooth muscle in the collecting system of the kidneys. This relaxation leads to dilation of the urinary collecting system and decreased bladder contraction, contributing to hydronephrosis. The gravid uterus also increases pressure on the ureters, promoting urinary stasis and further feeding hydronephrosis. Anatomic changes include an increase in kidney length by about 1–2 cm. The combination of ureteral compression by the uterus and smooth muscle relaxation helps explain why hydronephrosis is relatively common in pregnancy.

There is a notably elevated risk of kidney inflammations and upper urinary tract infections (pyelonephritis) during pregnancy. The risk is about 40% higher and is commonly caused by bacterial infection, usually Escherichia coli. These infections are more frequent on the right side, because the right ovarian vein crosses the right ureter before entering the pelvis, adding to urinary stasis and infection risk on that side.

Renal physiology and hormonal regulation in pregnancy

Pregnancy increases renal blood flow due to systemic vasodilation driven in part by relaxin. This vasodilation increases glomerular filtration rate (GFR) and renal filtration. Concurrently, the hormones that act on the kidneys rise to compensate for the hemodynamic changes: renin, angiotensin II, aldosterone, and antidiuretic hormone (ADH) all increase in response to lower blood pressure or reduced total peripheral resistance.

The net effect is sodium and water retention, contributing to the expanded plasma volume seen in pregnancy. Because of this water retention, plasma osmolality decreases modestly: from about $ext{plasma osmolality} \approx 290\ \text{mOsm/L}$ to about $\approx 280\ \text{mOsm/L}$ (a small decrease). Plasma sodium concentration also falls slightly.

There is a classic illustration of how renal homeostasis is overridden during pregnancy. Normally, increasing blood volume would feedback to reduce ADH secretion. However, pregnancy hormones—especially relaxin, estrogen, and progesterone—increase water and sodium retention by the kidneys, elevating blood volume. This elevated blood volume would normally lower ADH via reduced plasma osmolality, but relaxin provides a direct action on ADH secretion, effectively overriding the usual negative feedback. The result is a sustained increase in ADH secretion.

The rise in blood volume also increases atrial stretch, which stimulates atrial natriuretic peptide (ANP) release from the atria. ANP normally inhibits sodium reabsorption in the distal tubule. In pregnancy, however, the hormonal milieu overrides this effect, leading to net renal sodium retention.

Renin–angiotensin–aldosterone system (RAAS) activity would normally promote vasoconstriction via angiotensin II. Yet, high levels of relaxin and progesterone antagonize vasoconstriction, so the expected vasoconstrictive response is blunted during pregnancy.

A key point about ADH/vasopressin regulation is shown in the related graph: in normal physiology, plasma vasopressin rises with increasing plasma osmolality because osmoreceptors detect higher osmolality and trigger ADH release. In pregnancy, there are trimester-specific shifts:

• In the first trimester, the threshold for ADH secretion is reduced, so ADH is secreted at lower osmolalities than usual, reflecting a shift in osmoreceptor sensitivity.
• In the third trimester, the slope of the relationship between osmolality and vasopressin secretion decreases due to increased vasopressinases, enzymes that break down vasopressin. These shifts help explain why ADH activity is different in early and late pregnancy.

Gastrointestinal changes during pregnancy

Gastrointestinal (GI) changes are largely mediated by progesterone, which relaxes smooth muscle throughout the GI tract. This results in decreased motility and tone:

• The lower esophageal sphincter (LES) tone decreases, increasing the risk of gastroesophageal reflux (GERD) in about 30–50% of pregnancies. The reflux is further exacerbated by the uterus pressing upward on the stomach, increasing gastric pressure.
• Motilin secretion from M cells in the small intestine decreases, leading to reduced GI motility and slower intestinal transit. This prolongs water reabsorption in both the small and large intestines and contributes to constipation, a common symptom during pregnancy.

Musculoskeletal changes during pregnancy

Musculoskeletal adaptations during pregnancy are driven by the hormone relaxin, which facilitates remodeling of connective tissue to accommodate increased abdominal size and breast growth. The remodeling involves activation of collagenolytic systems that break down collagen to allow the tissues to stretch and reorganize.

These changes can produce mechanical discomfort and pain, including lower back pain. Additional pelvic changes include widening of the symphysis pubis, which can cause symphysis pubis dysfunction and related pain. Relaxin also increases mobility of the sacroiliac and sacrococcygeal joints in the first trimester, contributing to overall loosening of joints and tendons across the maternal musculoskeletal system.

Connections to broader physiology and practical implications

• The renal and hormonal adaptations support the expanded blood volume and uteroplacental perfusion needed during pregnancy but increase susceptibility to urinary tract infections and hydronephrosis due to mechanical and hormonal factors.
• The GI adaptations explain common symptoms such as reflux and constipation and underscore the role of progesterone and mechanical changes in GI function during pregnancy.
• The musculoskeletal adaptations, driven by relaxin, are essential for parturition-related changes but can lead to discomfort, pelvic girdle pain, and joint laxity.

Key numerical references and formulas

• Risk of inflammation of the kidneys and upper urinary tract infections: approximately a 40% increased risk.
• Reflux incidence in pregnancy: about 30–50%.
• Kidney length increase: about 1–2 cm.
• Plasma osmolality during pregnancy: decreases from approximately $290\ \text{mOsm/L}$ to $280\ \text{mOsm/L}$.
• UTI pathogens: commonly E. coli.

Summary of main mechanisms

• Hydronephrosis arises from progesterone- and relaxin-induced smooth muscle relaxation in the renal collecting system, plus uterine compression of the ureters causing urinary stasis.
• Renal hemodynamics shift to higher renal blood flow and GFR due to systemic vasodilation, with elevated RAAS hormones (renin, angiotensin II, aldosterone) and ADH promoting sodium and water retention.
• Despite changes that would typically lower ADH via reduced osmolality, relaxin and other hormones sustain higher ADH levels, contributing to edema and volume expansion.
• ANP release increases with volume expansion, but its natriuretic effect is overridden by pregnancy hormones, leading to net sodium retention.
• The timing of ADH regulation shifts across trimesters (lower threshold in the first trimester; reduced slope in the third due to vasopressinase activity).
• Progesterone-driven GI relaxation explains reflux and slowed transit with constipation as common consequences.
• Relaxin-mediated connective tissue remodeling prepares the pelvis and breasts for childbirth and lactation, albeit with potential back and pelvic pain due to increased joint laxity.